Hepatitis C virus-induced secretion of inflammatory chemokines preferentially recruits NKG2A+CD8+ T cells

Journal of Infectious Diseases

Volumn 198, Issue 2, 2008, Pages 213-217

  Nattermann, Jacob ^a   Sherzada, Roman ^a   Iwan, Agathe ^a   Bogen, Dominik ^a   Niederle, Ina Maria ^a   Schulte, Daniela ^a   Mertens, Eva ^a   Nischalke, Hans Dieter ^a   Krämer, Benjamin ^a   Sauerbruch, Tilman ^a   Leifeld, Ludger ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; HEPATITIS C VIRUS E2 ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; VIRUS ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LIVER; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD56; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CHEMOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HEPATITIS C; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; RECEPTORS, CCR5; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES; RNA, VIRAL; VIRAL CORE PROTEINS;

EID: 47649120416     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/589309     Document Type: Article

References (15)

1. Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R. T cell response in hepatitis C virus infection. J Clin Virol 2005; 32:75- 85.
2. Algood HM, Flynn JL. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 2004; 173:3287-96.
3. Nansen A, Christensen JP, Andreasen SO, Bartholdy C, Christensen JE, Thomsen AR. The role of CC chemokine receptor 5 in antiviral immunity. Blood 2002; 99:1237-45.
4. Goulding C, McManus R, Murphy A, et al. The CCR5-Δ32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut 2005; 54:1157-61.
5. Thio CL, Astemborski J, Bashirova A, et al. Genetic protection against hepatitis B virus conferred by CCR5Δ32: evidence that CCR5 contributes to viral persistence. J Virol 2007; 81:441-5.
6. Lanier LL. Face off - the interplay between activating and inhibitory immune receptors. Curr Opin Immunol 2001; 13:326-31.
7. + T cells. Trends Immunol 2003; 24:162-4.
8. Jabri B, Selby JM, Negulescu H, et al. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 2002; 17:487-99.
9. Moser JM, Gibbs J, Jensen PE, Lukacher AE. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol 2002; 3:189-95.
10. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002; 195:43-9.
11. Natterman J, Nischalke HD, Feldman G, Ahlenstiel G, Sauerbruch T, Spengler U. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J Viral Hepat 2004; 11:519-26.
12. Le Drean E, Vely F, Olcese L, et al. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 1998; 28:264-76.
13. Speiser DE, Pittet MJ, Valmori D, et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 1999; 190:775-82.
14. Nattermann J, Nischalke HD, Hofmeister V, et al. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol 2005; 166:443-53.
15. Nattermann J, Feldmann G, Ahlenstiel G, Langhans B, Sauerbruch T, Spengler U. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006; 55:869-77.